FDA Approves ACYCLOVIR — Viona Pharmaceuticals Inc
Viona Pharmaceuticals announced that the FDA has accepted and granted tentative approval for its generic acyclovir tablets, indicated for herpes infections, in ANDA No. 204313. Market implications include renewed pricing pressure and an expanded competitive landscape for established antiviral therapies following this regulatory milestone.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed